Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease

Autor: Takahashi K, Tashiro H, Tajiri R, Takamori A, Uchida M, Kato G, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 3297-3307 (2021)

Koichiro Takahashi,1 Hiroki Tashiro,1 Ryo Tajiri,2 Ayako Takamori,2 Masaru Uchida,3 Go Kato,4 Yuki Kurihara,1 Hironori Sadamatsu,1 Takashi Kinoshita,5 Makoto Yoshida,6 Atsushi Kawaguchi,2,7 Shinya Kimura,1 Naoko Sueoka-Aragane,1 Tomotaka Kawayama5 On

Externí odkaz: https://doaj.org/article/5500441045c64aac850c613a7e405a11

First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease

Autor: Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T

Publikováno v: International Journal of COPD, Vol Volume 15, Pp 2115-2126 (2020)

Koichiro Takahashi,1 Masaru Uchida,2 Go Kato,3 Ayako Takamori,4 Takashi Kinoshita,5 Makoto Yoshida,6 Ryo Tajiri,4 Keisuke Kojima,7 Hiroshi Inoue,8 Hiromi Kobayashi,9 Hironori Sadamatsu,1 Hiroki Tashiro,1 Masahide Tanaka,1 Shinichiro Hayashi,10 Atsush

Externí odkaz: https://doaj.org/article/4fa60b7c34284acd92cf1fcb4e9f9869

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Obesity affects pulmonary function in Japanese adult patients with asthma, but not those without asthma.

Autor: Tashiro H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan. si3222@cc.saga-u.ac.jp., Takahashi K; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan., Kurihara Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan., Sadamatsu H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan., Kuwahara Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan., Tajiri R; Clinical Research Center, Saga University Hospital, Saga, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan., Sueoka-Aragane N; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan.

Publikováno v: Scientific reports [Sci Rep] 2022 Sep 30; Vol. 12 (1), pp. 16457. Date of Electronic Publication: 2022 Sep 30.

The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model.

Autor: Sadamatsu H; Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Takahashi K; Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. takahak@cc.saga-u.ac.jp., Tashiro H; Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Kato G; Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Noguchi Y; Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan., Kurata K; Institute of Tokyo Environmental Allergy, Tokyo, Japan., Ōmura S; Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan., Kimura S; Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Sunazuka T; Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan., Sueoka-Aragane N; Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Publikováno v: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2020 Jan; Vol. 69 (1), pp. 139-151. Date of Electronic Publication: 2019 Dec 09.